News

SCCS Publishes Final Safety Opinions on Heliotropin and Acetophenone 

Different cosmetic cream, gel and foam textures displayed alongside wooden spatulas, illustrating cosmetic formulation and product testing.

The European Union’s Scientific Committee on Consumer Safety (SCCS) has published its final scientific opinions on the safety of Heliotropin and Acetophenone in cosmetic products. Announced by the European Commission on 15 October 2026, both assessments were conducted in the context of the substances’ proposed classification as Reproductive Toxicants Category 1B (Repr. 1B) under the EU Classification, Labelling and Packaging (CLP) Regulation. 

The SCCS concluded that Heliotropin is considered safe at concentrations of up to 1.8% in fine fragrance products intended for adults, while Acetophenone is considered safe at concentrations of up to 100 ppm (0.01%) in finished cosmetic products when present as a constituent of Natural Complex Substances (NCS). 

These scientific conclusions provide important guidance for cosmetic manufacturers, ingredient suppliers and responsible persons operating within the European Union market. 

Heliotropin: SCCS Confirms Safety up to 1.8% in Fine Fragrances for Adults 

Heliotropin (CAS No. 120-57-0) is a fragrance ingredient commonly used in perfume compositions and other fragranced products. 

Following its review of the available toxicological data and consumer exposure calculations, the SCCS concluded that Heliotropin is safe at a maximum concentration of 1.8% in fine fragrances intended exclusively for adults. 

The Committee highlighted several important limitations: 

  • The safety conclusion applies specifically to fine fragrance products intended for adults. 
  • The maximum concentration evaluated as safe is 1.8%. 
  • No definitive safety conclusion was established for other cosmetic product categories. 
  • Calculations submitted by the applicant indicated adequate margins of safety for additional product categories. However, these calculations do not constitute a separate SCCS safety conclusion for those uses. 

The final SCCS opinion on Heliotropin was adopted on 12 October 2026. 

For cosmetic manufacturers and fragrance suppliers, these findings highlight the importance of evaluating ingredient concentrations, intended product applications and consumer exposure conditions during cosmetic product safety assessments. 

Acetophenone: SCCS Establishes a Safe Level of 100 ppm in Finished Cosmetic Products 

Acetophenone (CAS No. 98-86-2) is a substance that may naturally occur in certain plant extracts, essential oils and other Natural Complex Substances (NCS). 

Unlike the Heliotropin assessment, the SCCS evaluation of Acetophenone specifically addressed its presence as a natural constituent of NCS rather than its intentional addition as an individual cosmetic ingredient. 

The Committee concluded that Acetophenone is considered safe when originating from NCS, provided that its concentration in the finished cosmetic product does not exceed 100 ppm (0.01%). 

What Does the 100 ppm Safety Level Mean? 

A concentration of 100 ppm corresponds to 0.01% of the finished cosmetic formulation. 

The SCCS assessment included several important considerations: 

  • The safety conclusion specifically concerns Acetophenone present as a constituent of Natural Complex Substances. 
  • The evaluation covers adults and children aged three years and above. 
  • Exposure from sources other than cosmetics, including food and tobacco smoke, was considered in the overall safety assessment. 
  • The Natural Complex Substances themselves were not assessed as part of this scientific opinion. 

The final SCCS opinion on Acetophenone was adopted on 14 October 2026. 

These findings are particularly relevant for cosmetic products containing botanical extracts, essential oils and other naturally derived ingredients. 

What Does Repr. 1B Classification Mean for Cosmetic Ingredients? 

Reproductive Toxicity Category 1B (Repr. 1B) is a hazard classification under Regulation (EC) No 1272/2008, commonly known as the CLP Regulation. 

This classification identifies substances presumed to be human reproductive toxicants, primarily on the basis of evidence obtained from animal studies. 

Under Article 15 of Regulation (EC) No 1223/2009, the use of substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR) is generally prohibited in cosmetic products, subject to specific conditions and possible exemptions. 

A favourable SCCS scientific opinion does not automatically constitute regulatory authorisation for unrestricted cosmetic use. 

The conclusions must be considered alongside the applicable legal requirements, including any relevant restrictions, exemptions and subsequent amendments to EU cosmetics legislation. 

Therefore, manufacturers should distinguish between a scientifically evaluated safe concentration and a legally authorised condition of use. 

What Should Cosmetic Manufacturers and Responsible Persons Consider? 

The final SCCS opinions provide new scientific reference points for assessing the use and presence of Heliotropin and Acetophenone in cosmetic formulations. 

Manufacturers, importers and responsible persons should consider the following actions: 

  1. Review ingredient compositions: Identify formulations containing Heliotropin or Acetophenone originating from Natural Complex Substances. 
  1. Verify concentrations: Compare the concentrations in finished products with the conditions evaluated in the SCCS opinions. 
  1. Review supplier documentation: Assess relevant ingredient specifications, composition information and supporting analytical data. 
  1. Update safety assessments where necessary: Consider the findings in the Cosmetic Product Safety Report (CPSR), taking into account the product category, target population and exposure conditions. 
  1. Monitor regulatory developments: Follow potential amendments to EU cosmetics legislation arising from the scientific and regulatory evaluation of these substances. 

Particular attention should be given to formulations containing essential oils and botanical extracts, where individual constituents may contribute to the overall exposure profile. 

Implications for Cosmetic Ingredient Safety and EU Compliance 

The final SCCS opinions on Heliotropin and Acetophenone reinforce the importance of evaluating cosmetic ingredient safety within clearly defined conditions of use. 

The SCCS considers Heliotropin safe at concentrations of up to 1.8% in fine fragrances intended for adults and Acetophenone safe at concentrations of up to 100 ppm when present as a constituent of Natural Complex Substances in finished cosmetic products. 

However, these findings should not be interpreted as unrestricted authorisation for use across all cosmetic product categories. 

For companies operating within the EU cosmetics market, the assessments highlight the need for scientifically supported formulation reviews, comprehensive cosmetic safety assessments and continued monitoring of regulatory developments.